Your Location:Home >Products >15687-27-1

15687-27-1

  • Product NameIbuprofen
  • Molecular FormulaC13H18O2
  • Purity99%
  • AppearanceColourless, crystalline solid
Inquiry

Product Details

Quick Details

  • CasNo: 15687-27-1
  • Molecular Formula: C13H18O2
  • Appearance: Colourless, crystalline solid
  • Purity: 99%

Buy USP Ibuprofen 15687-27-1 Factory Price

15687-27-1 Name

Name

Ibuprofen

Synonym

(+/-)-2-(4-ISOBUTYLPHENYL)-PROPIONIC ACID;2-(4-ISOBUTYLPHENYL)PROPIONIC ACID;4-ISOBUTYL-ALPHA-METHYLPHENYLACETIC ACID;AKOS NCG1-0060;(+/-)-ALPHA-METHYL-4-(2-METHYLPROPYL)-BENZENEACETIC ACID;ALPHA-METHYL-4-[2-METHYLPROPYL]BENZENEACETIC ACID;ALPHA-METHYL-4-(ISOBUTYL)PHENYLACETIC ACID;[A-METHYL-4-ISOBUTYL]PHENYLACETIC ACID

 

15687-27-1 Chemical & Physical Properties

Melting point 

77-78 °C(lit.)

Boiling point

319.6±11.0 °C at 760 mmHg

Density

1.0±0.1 g/cm3

Molecular Formula

C13H18O2

Molecular Weight

206.281

Flash Point

216.7±14.4 °C

PSA

37.30000

LogP

3.72

Exact Mass

206.130676

Vapour Pressure

0.0±0.7 mmHg at 25°C

Index of Refraction

1.519

Storage condition

-20°C Freezer

Stability

Stable. Combustible. Incompatible with strong oxidizing agents.

Water Solubility

insoluble

 

15687-27-1 Description

Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50 of 13 μM and 370 μM, respectively.

 

15687-27-1 Uses

A selective cyclooxygenase inhibitor (IC50=14.9uM). Inhibits PGH synthase-1 and PGH synthase-2 with comparable potency

 

 

Relevant articles

 

 

Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen

 

Khan,Akhter, Mymoona

, p. 371 - 376 (2005)

For reducing the gastrointestinal toxicity associated with ibuprofen its carboxylic group was condensed with the hydroxyl group of 1,2,3-trihydroxy propane 1,3-dipalmitate/stearate to give the ester prodrugs 3a and 3b. The release of ibuprofen from these prodrugs has been studied at pH 3, 4, 5 and 7.4 by HPLC using methanol and 0.05% phosphoric acid (80%) (70:30) as mobile phase. The prodrugs showed insignificant hydrolysis at pH 5 compared to pH 7.4 indicating that the prodrugs do not break in stomach but release ibuprofen at pH 7.4 in adequate amounts. In vivo hydrolysis studies in rats, the peak plasma concentration of ibuprofen was attained in 1.5:h in case of ibuprofen and in 2:h in prodrugs treated animals.


The continuous-flow synthesis of ibuprofen

 

Bogdan, Andrew R.,Poe, Sarah L.,Kubis, Daniel C.,Broadwater, Steven J.,McQuade, D. Tyler

, p. 8547 - 8550 (2009)

Let relief flow forth I A three-step, continuous-flow synthesis of ibuprofen was accomplished using a simplified microreactor. By designing a synthesis in which excess reagents and byproducts are compatible with downstream reactions, no intermediate purification or isolation steps are required.

;